23 Jan RoslinCT
Kevin Bruce, Chief Operating Officer
April 12 | 10:00am | Dark Horse Consulting Ballroom
RoslinCT is a leading cell therapy contract development and manufacturing organization (CDMO), enabling you to safely bring your autologous or allogeneic therapy to patients. We operate a fully licensed GMP manufacturing facility and have a proven track record in the delivery of cell-based products. We offer a range of integrated services from technology transfer, process, and assay development through to GMP manufacturing, storage, QP certification, and batch release of cell-based therapies for clinical trials. We also engage with leading cell and gene therapy developers providing a personalized service. At the heart of RoslinCT is a dynamic, highly experienced team that will understand your goals and will partner with you to get your therapy to market efficiently and effectively. We put quality and integrity at the heart of the business to make sure we provide you with the trust that your life-changing therapy is on the right pathway to commercialization.